CNR Institutional Research Information System

LAMPIASI, NADIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.998
NA - Nord America 1.066
EU - Europa 477
SA - Sud America 366
Continente sconosciuto - Info sul continente non disponibili 109
AF - Africa 30
OC - Oceania 2
Totale 4.048
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.010
SG - Singapore 768
CN - Cina 527
BR - Brasile 296
HK - Hong Kong 243
VN - Vietnam 178
IT - Italia 160
FR - Francia 110
NL - Olanda 94
KR - Corea 78
JP - Giappone 46
IN - India 43
AR - Argentina 33
BD - Bangladesh 32
GB - Regno Unito 26
CA - Canada 23
DE - Germania 23
FI - Finlandia 19
MX - Messico 14
EC - Ecuador 12
IL - Israele 11
KE - Kenya 9
ID - Indonesia 8
IQ - Iraq 8
UA - Ucraina 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
TR - Turchia 7
EG - Egitto 6
SA - Arabia Saudita 6
VE - Venezuela 6
JM - Giamaica 5
SE - Svezia 5
TT - Trinidad e Tobago 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
JO - Giordania 4
MA - Marocco 4
PH - Filippine 4
RU - Federazione Russa 4
AZ - Azerbaigian 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
LT - Lituania 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
PL - Polonia 3
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ES - Italia 2
HU - Ungheria 2
KZ - Kazakistan 2
LB - Libano 2
PK - Pakistan 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
TN - Tunisia 2
UY - Uruguay 2
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
IE - Irlanda 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
YE - Yemen 1
Totale 3.939
Salva come PNG Salva come JPEG
Città #
Singapore 463
Santa Clara 405
Hong Kong 237
Hefei 199
Beijing 109
San Jose 107
Ashburn 95
Lauterbourg 80
Seoul 77
Ho Chi Minh City 69
Los Angeles 42
Hanoi 35
Dallas 34
Tokyo 34
São Paulo 25
Palermo 23
New York 21
Mumbai 15
Frankfurt am Main 11
Helsinki 11
Montreal 11
Minamishinagawa 10
Rio de Janeiro 10
Bengaluru 9
Buffalo 9
Nairobi 9
Atlanta 8
Cagliari 8
Haiphong 8
Lappeenranta 8
Orem 8
Quito 8
Boardman 7
Milan 7
Belo Horizonte 6
Brasília 6
Da Nang 6
Houston 6
Porto Alegre 6
Amsterdam 5
Charlotte 5
Chennai 5
Contagem 5
Council Bluffs 5
Curitiba 5
Denver 5
Phoenix 5
Rome 5
Salvador 5
Tashkent 5
Belém 4
Brooklyn 4
Dhaka 4
Goiânia 4
Jacksonville 4
Kingston 4
Mexico City 4
Philadelphia 4
Poplar 4
Port of Spain 4
Stockholm 4
Thái Bình 4
Thái Nguyên 4
Abu Dhabi 3
Amman 3
Anápolis 3
Baku 3
Baltimore 3
Bexley 3
Biên Hòa 3
Buenos Aires 3
Bình An 3
Cairo 3
Chicago 3
Forest City 3
Guarulhos 3
Istanbul 3
Johannesburg 3
Kyiv 3
La Paz 3
Manaus 3
Miami 3
Naples 3
Ninh Bình 3
Portsmouth 3
Recife 3
Riyadh 3
Rosario 3
San Antonio 3
Santo André 3
Seattle 3
The Dalles 3
Acalanes Ridge 2
Anaheim 2
Ankara 2
Antioch 2
Aparecida de Goiânia 2
Betim 2
Birmingham 2
Bogotá 2
Totale 2.452
Salva come PNG Salva come JPEG
Nome #
A new ginger extract characterization: immunomodulatory, antioxidant effects and differential gene expression 116
The sea urchin embryo and the cell stress responses: new perspectives 94
Inflammation and the Potential Implication of Macrophage-Microglia Polarization in Human ASD: An Overview 91
Macrophage Polarization: Learning to Manage It 2.0 88
Mirnas expression profiling in raw264.7 macrophages after nfatc1-knockdown elucidates potential pathways involved in osteoclasts differentiation 87
Cationic Solid-lipid nanoparticles as DNA carriers. 82
Macrophage polarization: learning to manage it 81
Sperimento...ergo sum: Studenti al banco di laboratorio 80
Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells 78
Mast cell production of TNF-alpha induced by substance P evidence for a modulatory role of substance P-antagonists. 75
Sensing melanoma cells with hyaluronic acid decorated magnetoplasmonic nanoassemblies: from diagnosis to future therapeutic applications 71
New Strategies for Macrophage Re-Education in Cancer: An Update 66
COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. 62
Long-Lasting Activity of ERK Kinase Depends on NFATc1 Induction and Is Involved in Cell Migration-Fusion in Murine Macrophages RAW264.7 62
The novel NF-kB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism. 61
Neurotoxicity in marine invertebrates: An update 61
Fluorescent Magneto-Plasmonic Cyclodextrin Nanohybrids for Liquid Biopsy-Based Early Detection of Melanoma 61
The Alternative Faces of Macrophage Generate Osteoclasts 60
Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway 59
The Migration and the Fate of Dental Pulp Stem Cells 57
Gene Expression Profiling of NFATc1-Knockdown in RAW 264.7 Cells: An Alternative Pathway for Macrophage Differentiation 57
Probing safety of nano-objects by defining immune responses of environmental organisms 55
Osteoclasts differentiation from murine RAW 264.7 cells stimulated by RANKL: Timing and behavior 55
In silico insights and molecular characterization between IKK kinase and some ligands 55
Macrophage Polarization: Learning to Manage It 3.0 53
Development of nimesulide loaded solid lipid nanoparticles. 48
MITF: an evolutionarily conserved transcription factor in the sea urchin Paracentrotus lividus 47
Interactions between Macrophages and Mast Cells in the Female Reproductive System 47
Mesenchymal Stem Cells: What We Have Learned and How to Manage Them 46
Gli organismi viventi come esempio di plasticità e interazione con l'ambiente esterno 44
Substance P induces HO-1 expression in RAW 264.7 cells promoting switch towards M2-like macrophages 44
Regulation of the Phenotype and Function of Human Macrophages and Dendritic Cells by Exogenous Immunomodulators 43
COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells. 42
Toxic mineral elements in Mytilus galloprovincialis from Sicilian coasts (Southern Italy) 42
The response to simulated hypogravity is dependent on the proliferation state and temperature in FRTL-5 thyroid cells 39
Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism. 38
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. 38
Natural Molecules as IKK a/b Inhibitors useful in the Treatment of Inflammation 38
Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. 38
Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. 37
The molecular events behind ferulic acid mediated modulation of IL-6 expression in LPS-activated RAW 264.7 36
A factor secreted by human embryo stimulates cytokine release by uterine mast cell. 35
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells 35
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 34
Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells. 34
Molecular mechanisms of sorafenib action in liver cancer cells. 34
Cationic solid-lipid nanoparticles for gene delivery. 34
2015-2017 Accordo di cooperazione scientifica CNR/RFBR (Russian Foundation for Basic Research) : "Cell-cell fusion in vertebrate and invertebrate short-term cultures: ultrastructural, cellular and molecular analyses and role of ECM molecules, growth factors and miRNAs" 33
Cyclooxygenases in cancer 33
Microgravity and cellular homeostasis: effects of simulated hypogravity on FRTL-5 thyroid cells. 33
Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells. 32
Inhibitory effect of neuraminidase on SP-induced histamine release and TNF-alpha mRNA in rat mast cells: evidence of a receptor-independent mechanism. 32
Induction of apoptosis and inhibition of cells growth in human hepatocellular carcinoma cells by COX-2 inhibitors. 31
Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery 31
The novel NF-kB inhibitor DHMEQ suppresses the growth of human hepatic cancer cells through redox-dependent signaling. 31
Dispersal of rat uterine mast cells and their functional response to an embryo-derived histamine releasing factor: a possible model for embryo implantation. 30
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 30
Interaction between Embryo Histamine Releasing Factor (EHRF) and uterine mast cell. 29
Altered gene expression profiles in liver cancer cells upon sorafenib treatment. 29
Poly (ADP-ribose) polymerase inhibition synergizes with the NF-kB inhibitor DHMEQ to kill hepatocellular carcinoma cells 29
Combination of DHMEQ and Celecoxib synergistically exert anti-tumoral effects in human hepatoma cells. 29
Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells 28
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. 28
Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. 28
Gene expression profiling of human liver cancer cells following celecoxib treatment. 28
G. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. 28
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells 28
INVOLVEMENT OF p38 AND JNK mapks PATHWAYS IN SUBSTANCE P-INDUCED PRODUCTION OF TNF - BY PERITONEAL MAST CELLS 28
Effect of substance P on uterine mast cell cytokine release during the reproductive cycle. 28
Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells. 28
Solid-lipid nanoparticles for gene delivery to cells. 28
Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. 27
Induction of Apoptosis and Inhibition of Cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 27
Corrigendum to "Poly (ADP-ribose) polymerase inhibition synergizes with the NF-?B inhibitor DHMEQ to kill hepatocellular carcinoma cells" [Biochim. Biophys. Acta 1843 (2014) 2662-2673] 27
DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. 27
Modulation of rat peritoneal mast cell and human basophil histamine release by estrogens. 26
Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. 26
The multikinase inhibitor Sorafenib exhibits a strong cytotoxic effect in liver cancer cells through a MEK/ERK signaling-independent mechanism 26
DHMEQ and Celecoxib synergistically exert anti-tumoral activities in human liver cancer cells. 25
Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells 25
Altered gene expression profiles in liver cancer cells upon sorafenib treatment. 25
Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells 24
Substance P induces TNF-alpha and IL-6 production through NFkB in peritoneal mast cells 24
Growth suppression and apoptosis induction in human hepatoma cells by DHMEQ, a novel NF-KB inhibitor, is mediated through a ROS-dependent mechanism. 23
Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells 23
United we stand: Adhesion and molecular mechanisms driving cell fusion across speciestand 23
Microgravity and cellular homeostasis:effects of stimulated hypogravity on FRTL-5 thyroid cells. 23
Solid lipid nanoparticles (SLNs) containing nimesulide: preparation, characterization and in cytotoxicity studies 22
The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells 22
The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. 21
Antigens of Euparipha pisana (snail). I. Identification of allergens by means of in vivo and in vitro analysis. 21
HIF-1α as a Central Regulator of Monocyte Responses to Hypoxia 21
Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies. 21
DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. 21
Oestradiol enhances in vitro the histamine release induced by embryonic histamine-releasing factor (EHRF) from uterine mast cells. 20
Histamine and tumor necrosis factor-alpha production from purified rat brain mast cells mediated by substance P. 20
Estrogens and EHRF are important factors for the Embryo Implantation Step. 20
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells 20
Poly (ADP-ribose) polymerase inhibition synergizes with the NF-kB inhibitor DHMEQ to kill hepatocellular carcinoma cells. 19
Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism 16
Totale 4.017
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.082
article - articoli 7.924
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 304
Totale 21.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202455 0 0 0 0 0 0 0 0 34 12 4 5
2024/20251.478 17 7 93 42 370 72 20 91 58 86 348 274
2025/20262.400 164 247 250 385 402 94 309 162 145 118 67 57
2026/2027115 115 0 0 0 0 0 0 0 0 0 0 0
Totale 4.048